Duck hepatitis B virus covalently closed circular DNA appears to survive hepatocyte mitosis in the growing liver

Virology

Volumn 446, Issue 1-2, 2013, Pages 357-364

  Reaiche Miller, Georget Y ^a   Thorpe, Michael ^a   Low, Huey Chi ^a   Qiao, Qiao ^a   Scougall, Catherine A ^a   Mason, William S ^b   Litwin, Samuel ^b   Jilbert, Allison R ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

Covalently closed circular DNA (cccDNA); Duck hepatitis B virus (DHBV); Entecavir (ETV); Hepatitis B virus (HBV); Hepatocyte mitosis; Nucleoside analogue; Survival or loss of cccDNA

Indexed keywords

CIRCULAR DNA; COVALENTLY CLOSED CIRCULAR DNA; ENTECAVIR; HEPATITIS B SURFACE ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL THERAPY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; DUCK HEPATITIS B; DUCK HEPATITIS B VIRUS; DUCKLING; LIVER CELL; LIVER SIZE; LIVER WEIGHT; MITOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIREMIA;

COVALENTLY CLOSED CIRCULAR DNA (CCCDNA); DUCK HEPATITIS B VIRUS (DHBV); ENTECAVIR (ETV); HEPATITIS B VIRUS (HBV); HEPATOCYTE MITOSIS; NUCLEOSIDE ANALOGUE; SURVIVAL OR LOSS OF CCCDNA;

ANIMALS; ANTIVIRAL AGENTS; DNA, CIRCULAR; DNA, VIRAL; DUCKS; GUANINE; HEPATITIS B VIRUS, DUCK; HEPATOCYTES; LIVER; MITOSIS; VIRUS REPLICATION;

EID: 84884575067     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.08.014     Document Type: Article

References (42)

1. Alison M.R. Characterization of the differentiation capacity of rat-derived hepatic stem cells. Semin. Liver Dis. 2003, 23:325-336.
2. Dresang L.R., Vereide D.T., Sugden B. Identifying sites bound by Epstein-Barr virus nuclear antigen 1 (EBNA1) in the human genome: defining a position-weighted matrix to predict sites bound by EBNA1 in viral genomes. J. Virol. 2009, 83:2930-2940.
3. Feeney K.M., Parish J.L. Targeting mitotic chromosomes: a conserved mechanism to ensure viral genome persistence. Proc. Biol. Sci. 2009, 276:1535-1544.
4. Foster W.K., Miller D.S., Marion P.L., Colonno R.J., Kotlarski I., Jilbert A.R. Entecavir therapy combined with DNA vaccination for persistent duck hepatitis B virus infection. Antimicrob. Agents Chemother. 2003, 47:2624-2635.
5. Foster W.K., Miller D.S., Scougall C.A., Kotlarski I., Colonno R.J., Jilbert A.R. The effect of antiviral treatment with entecavir on age- & dose-related outcomes of duck hepatitis B virus infection. J. Virol. 2005, 79(9):5819-5832.
6. Fourel I., Cullen J.M., Saputelli J., Aldrich C.E., Schaffer P., Averett D.R., Pugh J., Mason W.S. Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks. J. Virol. 1994, 68:8321-8330.
7. Goetz M., Ansems J.V., Galle P.R., Schuchmann M., Kiesslich R. In vivo real-time imaging of the liver with confocal endomicroscopy permits visualization of the temporospatial patterns of hepatocyte apoptosis. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 301:G764-772.
8. Guo H., Jiang D., Zhou T., Cuconati A., Block T.M., Guo J.T. Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation. J. Virol. 2007, 81:12472-12484.
9. Jilbert A.R., Miller D.S., Scougall C.A., Turnbull H., Burrell C.J. Kinetics of duck hepatitis B virus infection following low dose virus inoculation: one virus DNA genome is infectious in neonatal ducks. Virology 1996, 226:338-345.
10. Jilbert A.R., Wu T.T., England J.M., Hall P.M., Carp N.Z., O'Connell A.P., Mason W.S. Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement. J. Virol. 1992, 66:1377-1388.
11. Kajino K., Jilbert A.R., Saputelli J., Aldrich C.E., Cullen J., Mason W.S. Woodchuck hepatitis virus infections: very rapid recovery after a prolonged viremia and infection of virtually every hepatocyte. J. Virol. 1994, 68:5792-5803.
12. Kennedy S., Rettinger S., Flye M.W., Ponder K.P. Experiments in transgenic mice show that hepatocytes are the source for postnatal liver growth and do not stream. Hepatology 1995, 22:160-168.
13. Kock J., Schlicht H.J. Analysis of the earliest steps of hepadnavirus replication: genome repair after infectious entry into hepatocytes does not depend on viral polymerase activity. J. Virol. 1993, 67:4867-4874.
14. Krishan A., Dandekar P., Nathan N., Hamelik R., Miller C., Shaw J. DNA index, genome size, and electronic nuclear volume of vertebrates from the Miami Metro Zoo. Cytometry A 2005, 65:26-34.
15. Kuhlmann W.D., Peschke P. Hepatic progenitor cells, stem cells, and AFP expression in models of liver injury. Int. J. Exp. Pathol. 2006, 87:343-359.
16. Le Mire M.F., Miller D.S., Foster W.K., Burrell C.J., Jilbert A.R. Covalently closed circular DNA is the predominant form of duck hepatitis B virus DNA that persists following transient infection. J. Virol. 2005, 79:12242-12252.
17. Levrero M., Pollicino T., Petersen J., Belloni L., Raimondo G., Dandri M. Control of cccDNA function in hepatitis B virus infection. J. Hepatol. 2009, 51:581-592.
18. Lien J.M., Petcu D.J., Aldrich C.E., Mason W.S. Initiation and termination of duck hepatitis B virus DNA synthesis during virus maturation. J. Virol. 1987, 61:3832-3840.
19. Luscombe C., Pedersen J., Uren E., Locarnini S. Long-term ganciclovir chemotherapy for congenital duck hepatitis B virus infection in vivo: effect on intrahepatic-viral DNA, RNA, and protein expression. Hepatology 1996, 24:766-773.
20. Mason W., Litwin S. Pathogenesis of Hepadnavirus Infections. Hepatitis B Virus 2002, 99-114. International Medical Press, London. C. Lai, S. Locarnini (Eds.).
21. Mason W.S., Cullen J., Saputelli J., Wu T.T., Liu C., London W.T., Lustbader E., Schaffer P., O'Connell A.P., Fourel I., et al. Characterization of the antiviral effects of 2' carbodeoxyguanosine in ducks chronically infected with duck hepatitis B virus. Hepatology 1994, 19:398-411.
22. Meier P., Scougall C.A., Will H., Burrell C.J., Jilbert A.R. A duck hepatitis B virus strain with a knockout mutation in the putative X ORF shows similar infectivity and in vivo growth characteristics to wild-type virus. Virology 2003, 317:291-298.
23. Miller D.S., Bertram E.M., Scougall C.A., Kotlarski I., Jilbert A.R. Studying host immune responses against duck hepatitis B virus infection. Methods Mol. Med. 2004, 96:3-25.
24. Miller R.H., Robinson W.S. Hepatitis B virus DNA forms in nuclear and cytoplasmic fractions of infected human liver. Virology 1984, 137:390-399.
25. Moraleda G., Saputelli J., Aldrich C.E., Averett D., Condreay L., Mason W.S. Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus. J. Virol. 1997, 71:9392-9399.
26. Nejak-Bowen K., Orr A., Bowen W.C., Michalopoulos G.K. Conditional genetic elimination of hepatocyte growth factor in mice compromises liver regeneration after partial hepatectomy. PloS ONE 2013, 8:e59836.
27. Pollicino T., Belloni L., Raffa G., Pediconi N., Squadrito G., Raimondo G., Levrero M. Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones. Gastroenterology 2006, 130:823-837.
28. Pugh J.C., Di Q., Mason W.S., Simmons H. Susceptibility to duck hepatitis B virus infection is associated with the presence of cell surface receptor sites that efficiently bind viral particles. J. Virol. 1995, 69:4814-4822.
29. Raimondo G., Pollicino T., Romano L., Zanetti A.R. A 2010 update on occult hepatitis B infection. Pathol. Biol. (Paris) 2010, 58:254-257.
30. Reaiche G.Y., Le Mire M.F., Mason W.S., Jilbert A.R. The persistence in the liver of residual duck hepatitis B virus covalently closed circular DNA is not dependent upon new viral DNA synthesis. Virology 2010, 406:286-292.
31. Selden J.R., Dolbeare F., Clair J.H., Miller J.E., McGettigan K., DiJohn J.A., Dysart G.R., DeLuca J.G. Validation of a flow cytometric in vitro DNA repair (UDS) assay in rat hepatocytes. Mutat. Res. 1994, 315:147-167.
32. Summers J., Jilbert A.R., Yang W., Aldrich C.E., Saputelli J., Litwin S., Toll E., Mason W.S. Hepatocyte turnover during resolution of a transient hepadnaviral infection. Proc. Natl. Acad. Sci. USA 2003, 100:11652-11659.
33. Summers J., Mason W.S. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 1982, 29:403-415.
34. Taupin P. BrdU immunohistochemistry for studying adult neurogenesis: paradigms, pitfalls, limitations, and validation. Brain Res. Rev. 2007, 53:198-214.
35. Tiersch T.R., Wachtel S.S. On the evolution of genome size of birds. J. Hered. 1991, 82:363-368.
36. Triyatni M., Ey P., Tran T., Le Mire M., Qiao M., Burrell C., Jilbert A. Sequence comparison of an Australian duck hepatitis B virus strain with other avian hepadnaviruses. J. Gen. Virol. 2001, 82:373-378.
37. Tuttleman J.S., Pourcel C., Summers J. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell 1986, 47:451-460.
38. Wang C.Y., Sugden B. Identifying a property of origins of DNA synthesis required to support plasmids stably in human cells. Proc. Natl. Acad. Sci. USA 2008, 105:9639-9644.
39. Wu T.T., Coates L., Aldrich C.E., Summers J., Mason W.S. In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway. Virology 1990, 175:255-261.
40. Zhang Y.Y., Summers J. Low dynamic state of viral competition in a chronic avian hepadnavirus infection. J. Virol. 2000, 74:5257-5265.
41. Zhang Y.Y., Zhang B.H., Theele D., Litwin S., Toll E., Summers J. Single-cell analysis of covalently closed circular DNA copy numbers in a hepadnavirus-infected liver. Proc. Natl. Acad. Sci. USA 2003, 100:12372-12377.
42. Zhu Y., Yamamoto T., Cullen J., Saputelli J., Aldrich C.E., Miller D.S., Litwin S., Furman P.A., Jilbert A.R., Mason W.S. Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis. J. Virol. 2001, 75:311-322.